Ticker Details
Royalty Pharma plc
IPO Date:	June 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$19.33B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.44 | 1.18%
Avg Daily Range (30 D):	$0.35 | 0.83%
Avg Daily Range (90 D):	$0.41 | 1.05%

Institutional Daily Volume
Avg Daily Volume:	2.12M
Avg Daily Volume (30 D):	3.12M
Avg Daily Volume (90 D):	2.97M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	84
Avg Trade Size (Sh.) (90 D):	81

Institutional Trades
Total Institutional Trades:	9,233
Avg Institutional Trade:	$4.79M
Avg Institutional Trade (30 D):	$5.56M
Avg Institutional Trade (90 D):	$6.79M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	6

Market Closing Trades
Avg Closing Trade:	$14.21M
Avg Closing Trade (30 D):	$22.6M
Avg Closing Trade (90 D):	$23.24M
Avg Closing Volume:	396.94K

News

Jan 11, 2026 @ 11:00 PM Teva to Present at the 44th Annual J.P. Morgan Hea... Source: Na

Jan 11, 2026 @ 10:15 PM Royalty Pharma and Teva Enter Agreement to Acceler... Source: Na

Jan 11, 2026 @ 10:00 PM Teva and Royalty Pharma Enter Agreement to Acceler... Source: Na

Jan 9, 2026 @ 1:30 PM Royalty Pharma Announces Dividend Increase Source: Globe Newswire

Jan 9, 2026 @ 6:52 AM Merck In Talks To Buy Cancer Drug-Maker Revolution... Source: Vishaal Sanjay

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$1.79	$.5	$1.79
Diluted EPS	$1.78	$.5	$1.78
Revenue	$2.38B	$621.99M	$2.38B
Gross Profit
Net Income / Loss	$1.32B	$355.91M	$1.32B
Operating Income / Loss	$1.56B	$388.38M	$1.56B
Cost of Revenue
Net Cash Flow	$-310.33M	$-320.25M	$-310.33M
PE Ratio	25.51

Splits
Oct 15, 2010	1:4